Showing results (271-280 of 303) with videos related to
Sort By:
Pageof 31
Diabetologia|July 1, 1995
Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study)P Pozzilli, N Visalli, A Signore, et al.Thrombosis and Haemostasis|December 1, 1995
Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitorsM Colucci, L Gesualdo, P Montemurro, et al.Journal of Helminthology|November 20, 2024
Morphological and genetic analysis of a rediscovered Clinostomum sp. parasitising Titanolebias monstrosus and Trigonectes aplocheiloides (Cyprinodontiformes: Rivulidae)M M Montes, F Alonso, G E Terán, et al.Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1994
Randomized trial comparing nicotinamide and nicotinamide plus cyclosporin in recent onset insulin-dependent diabetes (IMDIAB 1). The IMDIAB Study GroupP Pozzilli, N Visalli, M L Boccuni, et al.Diabete & Metabolisme|February 1, 1995
Adjuvant therapy in recent onset type 1 diabetes at diagnosis and insulin requirement after 2 yearsP Pozzilli, N Visalli, R Buzzetti, et al.Diabetes Care|August 1, 1994
Combination of nicotinamide and steroid versus nicotinamide in recent-onset IDDM. The IMDIAB II StudyP Pozzilli, N Visalli, M L Boccuni, et al.Restorative Neurology and Neuroscience|August 8, 2012
Inter-hemispheric coupling changes associate with motor improvements after robotic stroke rehabilitationG Pellegrino, L Tomasevic, M Tombini, et al.The Journal of Clinical Endocrinology and Metabolism|December 16, 2004
Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver diseaseF Angelico, M Del Ben, R Conti, et al.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 25, 2010
Intrafascicular thin-film multichannel electrodes for sensory feedback: Evidences on a human amputeeA Benvenuto, S Raspopovic, K P Hoffmann, et al.British Journal of Cancer|August 12, 2004
Phase II trial of carboplatin and etoposide for patients with recurrent high-grade gliomaE Franceschi, G Cavallo, L Scopece, et al.Pageof 31